Skip to main content
Equibles

MARSHALL WACE, LLP

Position in OKUR — OnKure Therapeutics, Inc.

CIK 1318757 LONDON, X0
Back to OKUR Full portfolio

Position in OKUR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$729,056
+$578,178 QoQ
Shares Held
159,881
+338.7% QoQ
Ownership
0.395%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 75 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in OKUR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. OKUR ranks #201 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 543,897 $270,169,956
2 INCY
Incyte Corp
 1,310,154 $148,519,056
3 RPRX
Royalty Pharma plc
 2,450,669 $137,409,009
4 SYRE
Spyre Therapeutics, Inc.
 991,693 $88,042,503
5 ALNY
Alnylam Pharmaceuticals, Inc.
 259,799 $78,207,292
6 TVTX
Travere Therapeutics, Inc.
 1,333,207 $75,739,488
7 MANE
Veradermics, Inc
 585,560 $71,988,746
8 DFTX
Definium Therapeutics, Inc.
 1,298,946 $61,102,419

All Filings in OKUR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $729,056 159,881
2026-03-31 $150,878 36,444